In-depth process understanding of RECOMBIVAX HB® maturation and potential epitope improvements with redox treatment: Multifaceted biochemical and immunochemical characterization (Q84839058)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 25, 2011

Language	Label	Description	Also known as
English	In-depth process understanding of RECOMBIVAX HB® maturation and potential epitope improvements with redox treatment: Multifaceted biochemical and immunochemical characterization	scientific article published on August 25, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

In-depth process understanding of RECOMBIVAX HB® maturation and potential epitope improvements with redox treatment: multifaceted biochemical and immunochemical characterization (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

In-depth process understanding of RECOMBIVAX HB® maturation and potential epitope improvements with redox treatment: Multifaceted biochemical and immunochemical characterization (English)

1 reference

10.1016/J.VACCINE.2011.08.070

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.070

10 December 2024

0 references

author name string

Qinjian Zhao

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Victoria Towne

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Martha Brown

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Yang Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Dicky Abraham

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ronald Kennedy

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

C. Brent Oswald

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21871939

10 December 2024

Juan A. Gimenez

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21871939

10 December 2024

Michael W. Washabaugh

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21871939

10 December 2024

Robert D. Sitrin

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21871939

10 December 2024

language of work or name

0 references

publication date

25 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

full work available at URL

https://api.elsevier.com/content/article/PII:S0264410X11013296?httpAccept=text/xml

1 reference

10.1016/J.VACCINE.2011.08.070

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.070

10 December 2024

https://api.elsevier.com/content/article/PII:S0264410X11013296?httpAccept=text/plain

1 reference

10.1016/J.VACCINE.2011.08.070

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.070

10 December 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

7936-7941

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Reduction of animal use in human vaccine quality control: opportunities and problems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

The potential of physicochemical and immunochemical assays to replace animal tests in the quality control of toxoid vaccines. The report and recommendations of ECVAM workshop 61

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Correlation between mouse potency and in vitro relative potency for human papillomavirus Type 16 virus-like particles and Gardasil vaccine samples

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Quality control of routine, experimental and real-time aged diphtheria toxoids by in vitro analytical techniques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Quality-control issues and approaches in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Human hepatitis B vaccine from recombinant yeast

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Multiple chemical forms of hepatitis B surface antigen produced in yeast

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Maturation of recombinant hepatitis B virus surface antigen particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Real time monitoring of antigenicity development of HBsAg virus-like particles (VLPs) during heat- and redox-treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Structural characterization of viral neutralizing monoclonal antibodies to hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Enhanced sensitivity and precision in an enzyme-linked immunosorbent assay with fluorogenic substrates compared with commonly used chromogenic substrates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Determination of picomolar equilibrium dissociation constants in solution by enzyme-linked immunosorbent assay with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

A function essential to viral entry underlies the hepatitis B virus "a" determinant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

Secretion and Antigenicity of Hepatitis B Virus Small Envelope Proteins Lacking Cysteines in the Major Antigenic Region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.08.070

7 January 2021

In vitro versus in vivo concordance: a case study of the replacement of an animal potency test with an immunochemical assay

3

1 reference

10.1016/J.VACCINE.2011.08.070

https://api.crossref.org/works/10.1016/J.VACCINE.2011.08.070

10 December 2024

Identifiers

10.1016/J.VACCINE.2011.08.070

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21871939%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84839058&oldid=2285846734"